+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medicinal Radiocompounds Market - Global Forecast 2026-2032- Product Image
Medicinal Radiocompounds Market - Global Forecast 2026-2032- Product Image
Sale

Medicinal Radiocompounds Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6279059
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medicinal Radiocompounds: Executive Overview

Medicinal radiocompounds combine a radioactive isotope with a targeting molecule for diagnostic imaging or targeted treatment. Their development depends on isotope availability, radiochemistry, molecular targeting, clinical evidence, radiation-safety systems, specialized infrastructure, and coordinated regulation. The field is advancing from predominantly diagnostic applications toward integrated theranostic approaches that pair disease visualization with targeted radionuclide therapy.

From Imaging Products to Integrated Theranostic Care

The landscape is shifting toward radiocompounds designed around complete care pathways rather than isolated products. Important changes include wider use of personalized dosimetry, greater interest in alpha- and beta-emitting therapeutic isotopes, increased integration of nuclear medicine with oncology, and stronger emphasis on manufacturing continuity. These shifts make logistics, hospital readiness, isotope qualification, and multidisciplinary clinical workflows as important as molecular innovation.

How Artificial Intelligence Is Reshaping Radiocompound Development

Artificial intelligence is contributing to image reconstruction, lesion detection, segmentation, response assessment, patient selection, and treatment-planning support. It can also help researchers identify molecular targets, optimize radioligand designs, analyze pharmacokinetic data, and improve production scheduling. Safe deployment requires representative training data, external validation, explainable outputs, cybersecurity, and human oversight, particularly where algorithmic recommendations influence radiation exposure or treatment eligibility.

Regional Insights Across the Radiocompounds Landscape

North America benefits from advanced nuclear medicine infrastructure, specialized clinical research, and established regulatory capabilities, while Latin America is shaped by uneven access to cyclotrons, radiopharmacies, reimbursement, and trained personnel. Europe has strong academic and clinical networks, with cross-border coordination especially relevant to isotope transport and quality standards. The Middle East is investing in advanced healthcare capacity but must align specialist training with supply reliability. Africa faces wider disparities in imaging access, isotope distribution, and technical workforce development. Asia-Pacific combines substantial research and manufacturing capabilities with rapidly expanding clinical demand, while access remains uneven across economies and islands.

Group Perspectives: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN economies present opportunities for regional coordination in isotope logistics, regulatory alignment, and specialist training, although infrastructure varies considerably. BRICS members span major research, manufacturing, and healthcare systems, making collaboration on production resilience and clinical capacity relevant while national requirements remain distinct. The European Union benefits from harmonization efforts and interconnected research networks. G7 countries provide substantial scientific, regulatory, and clinical leadership. GCC states are strengthening high-acuity healthcare capabilities, with workforce development and supply continuity remaining priorities. NATO members have broad technical capabilities, but the group is not a unified healthcare or market-regulatory framework, so radiocompound policies continue to be determined nationally or through relevant regional institutions.

Country Insights: Diverse Capabilities and Access Conditions

Australia combines strong research capacity with geographic distribution challenges. Brazil and Mexico are expanding specialized healthcare capabilities while facing regional access and infrastructure differences. Canada and the United States have sophisticated clinical, regulatory, and research ecosystems, alongside complex reimbursement and supply-chain requirements. China, India, Japan, and South Korea possess substantial scientific and manufacturing capabilities, with differing regulatory pathways and healthcare delivery models. France, Germany, Italy, Spain, and the United Kingdom have mature nuclear medicine communities supported by specialist hospitals and research networks, while procurement, isotope access, and national health-system processes vary. Russia maintains relevant scientific and nuclear capabilities, although international connectivity and supply arrangements can affect collaboration and access.

Priorities for Leaders Building Resilient Radiocompound Programs

Industry leaders should design development programs around validated clinical use cases, companion imaging, dosimetry, and patient-selection criteria from the outset. They should diversify isotope and critical-material sources, qualify backup manufacturing and transport routes, and establish release testing that supports consistent product quality. Partnerships with hospitals and academic centers can accelerate workflow validation and workforce training. Leaders should also prepare evidence packages for regulators and payers, implement robust radiation-safety governance, and apply artificial intelligence only through controlled validation, monitoring, and clinician-supervised deployment.

Research Methodology for the Executive Summary

This summary uses a structured interpretation of the medicinal radiocompounds field, covering diagnostic and therapeutic radiocompounds, their enabling technologies, clinical workflows, supply chains, regulation, and artificial-intelligence applications. Insights are organized by region, multinational grouping, and country to distinguish common structural themes from local variation. The analysis emphasizes publicly verifiable industry characteristics and avoids unsupported numerical claims, market estimates, company-specific conclusions, and forecasts.

Conclusion: Coordinating Science, Supply, and Clinical Delivery

Medicinal radiocompounds are advancing through the convergence of molecular targeting, nuclear medicine, oncology, data science, and specialized manufacturing. Progress will depend not only on scientific results but also on reliable isotope supply, fit-for-purpose facilities, trained teams, regulatory coordination, and equitable patient access. Organizations that integrate these elements into a single operating strategy will be better positioned to translate radiocompound innovation into safe, reproducible clinical care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medicinal Radiocompounds Market, by Product Type
7.1. Introduction
7.2. Diagnostic
7.2.1. PET Radiotracers
7.2.1.1. 11C Tracers
7.2.1.2. 18F Tracers
7.2.1.3. 64Cu Tracers
7.2.1.4. 68Ga Tracers
7.2.2. SPECT Radiotracers
7.2.2.1. 111In Tracers
7.2.2.2. 123I Tracers
7.2.2.3. 99mTc Kits
7.2.3. Theranostic Agents
7.2.3.1. Companion Diagnostic Kits
7.2.3.2. Dual Function Agents
7.2.3.3. Paired Diagnostic-Therapeutic Agents
7.2.4. Therapeutic Radiopharmaceuticals
7.2.4.1. Alpha Emitters
7.2.4.1.1. 211At
7.2.4.1.2. 223Ra
7.2.4.1.3. 225Ac
7.2.4.2. Auger Emitters
7.2.4.3. Beta Emitters
7.2.4.3.1. 177Lu
7.2.4.3.2. 90Y
7.2.4.4. Radioconjugates
7.3. Research Use Only Products
7.4. Therapeutic
7.4.1. Antibody Based Therapeutics
7.4.2. Peptide Based Therapeutics
7.4.3. Small Molecule Therapeutics
8. Medicinal Radiocompounds Market, by Radioisotope Type
8.1. Introduction
8.2. PET Isotopes
8.2.1. Carbon 11
8.2.2. Copper 64
8.2.3. Fluorine 18
8.2.4. Gallium 68
8.2.5. Zirconium 89
8.3. SPECT Isotopes
8.3.1. Indium 111
8.3.2. Iodine 123
8.3.3. Technetium 99m
8.4. Therapeutic Isotopes
8.4.1. Actinium 225
8.4.2. Lutetium 177
8.4.3. Radium 223
8.4.4. Yttrium 90
9. Medicinal Radiocompounds Market, by Production Method
9.1. Introduction
9.2. Cyclotron Produced
9.2.1. Centralized Cyclotron
9.2.2. Onsite Cyclotron
9.2.3. Outsourced Cyclotron Services
9.3. Generator Produced
9.3.1. 68Ge/68Ga Generators
9.3.2. 99Mo/99mTc Generators
9.4. Radiopharmacy Synthesis Services
9.5. Reactor And Accelerator
9.5.1. Accelerator Sourced Production
9.5.2. Reactor Sourced Production
10. Medicinal Radiocompounds Market, by Therapeutic Mechanism
10.1. Introduction
10.2. Antibody Based
10.2.1. Antibody Fragments And Conjugates
10.2.2. Monoclonal Antibodies
10.3. Cell Based Radiotherapies
10.4. Nanoparticle Based
10.5. Peptide Based
10.5.1. Peptide Receptor Targeting
10.5.2. Radiolabeled Peptides
10.6. Small Molecule Targeting
11. Medicinal Radiocompounds Market, by Application
11.1. Introduction
11.2. Cardiology
11.2.1. Cardiac Viability
11.2.2. Myocardial Perfusion
11.3. Neurology
11.3.1. Alzheimer Disease Imaging
11.3.2. Parkinsonian Disorder Imaging
11.4. Oncology
11.4.1. General Oncology Imaging
11.4.2. Neuroendocrine Tumor Imaging And PRRT
11.4.3. Prostate Cancer Imaging And Therapy
12. Medicinal Radiocompounds Market, by End User
12.1. Introduction
12.2. Contract Manufacturing Organizations
12.3. Diagnostic Imaging Centers
12.4. Hospitals
12.5. Nuclear Medicine Clinics
12.6. Pharmaceutical And Biotech Companies
12.7. Research Institutes
13. Medicinal Radiocompounds Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Medicinal Radiocompounds Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Medicinal Radiocompounds Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Advanced Accelerator Applications S.A.
17.2. Bayer AG
17.3. Bracco Imaging S.p.A.
17.4. Cardinal Health Inc.
17.5. Curium Pharma US LLC
17.6. GE Healthcare
17.7. Ion Beam Applications S.A.
17.8. Jubilant Radiopharma Pvt Ltd.
17.9. Lantheus Medical Imaging Inc.
17.10. Mallinckrodt Pharmaceuticals
17.11. Nordion Inc.
17.12. Novartis AG
17.13. PETNET Solutions Inc.
17.14. RadioMedix Inc.
17.15. Siemens Healthineers AG
17.16. Telix Pharmaceuticals Limited
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medicinal Radiocompounds Market, Years Considered for the Study
FIGURE 2. Global Medicinal Radiocompounds Market, Research Design
FIGURE 3. Global Medicinal Radiocompounds Market, Research Framework
FIGURE 4. Global Medicinal Radiocompounds Market, Data Triangulation
FIGURE 5. Global Medicinal Radiocompounds Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medicinal Radiocompounds Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Medicinal Radiocompounds Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medicinal Radiocompounds Market Size, by Radioisotope Type, 2025 vs 2032 (%)
FIGURE 9. Global Medicinal Radiocompounds Market Size, by Radioisotope Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medicinal Radiocompounds Market Size, by Production Method, 2025 vs 2032 (%)
FIGURE 11. Global Medicinal Radiocompounds Market Size, by Production Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medicinal Radiocompounds Market Size, by Therapeutic Mechanism, 2025 vs 2032 (%)
FIGURE 13. Global Medicinal Radiocompounds Market Size, by Therapeutic Mechanism, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medicinal Radiocompounds Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Medicinal Radiocompounds Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medicinal Radiocompounds Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Medicinal Radiocompounds Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medicinal Radiocompounds Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Medicinal Radiocompounds Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Medicinal Radiocompounds Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medicinal Radiocompounds Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Medicinal Radiocompounds Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Medicinal Radiocompounds Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medicinal Radiocompounds Market Segmentation & Coverage
TABLE 2. Global Medicinal Radiocompounds Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medicinal Radiocompounds Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global PET Radiotracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global PET Radiotracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global PET Radiotracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 11C Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 11C Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 11C Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global 18F Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global 18F Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global 18F Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global 64Cu Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global 64Cu Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global 64Cu Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global 68Ga Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global 68Ga Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global 68Ga Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global SPECT Radiotracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global SPECT Radiotracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global SPECT Radiotracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global 111In Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global 111In Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global 111In Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global 123I Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global 123I Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global 123I Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global 99mTc Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global 99mTc Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global 99mTc Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Theranostic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Theranostic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Theranostic Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Companion Diagnostic Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Companion Diagnostic Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Companion Diagnostic Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Dual Function Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Dual Function Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Dual Function Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Paired Diagnostic-Therapeutic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Paired Diagnostic-Therapeutic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Paired Diagnostic-Therapeutic Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Therapeutic Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Alpha Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Alpha Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Alpha Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global 211At Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global 211At Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global 211At Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global 223Ra Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global 223Ra Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global 223Ra Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global 225Ac Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global 225Ac Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global 225Ac Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Auger Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Auger Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Auger Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Beta Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Beta Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Beta Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global 177Lu Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global 177Lu Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global 177Lu Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global 90Y Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global 90Y Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global 90Y Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Radioconjugates Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Radioconjugates Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Radioconjugates Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Research Use Only Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Research Use Only Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Research Use Only Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Antibody Based Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Antibody Based Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Antibody Based Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Peptide Based Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Peptide Based Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Peptide Based Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Small Molecule Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Small Molecule Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Small Molecule Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Medicinal Radiocompounds Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 92. Global PET Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global PET Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global PET Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Carbon 11 Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Carbon 11 Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Carbon 11 Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Copper 64 Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Copper 64 Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Copper 64 Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Fluorine 18 Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Fluorine 18 Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Fluorine 18 Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Gallium 68 Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Gallium 68 Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Gallium 68 Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Zirconium 89 Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Zirconium 89 Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Zirconium 89 Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global SPECT Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global SPECT Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global SPECT Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Indium 111 Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Indium 111 Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Indium 111 Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Iodine 123 Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Iodine 123 Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Iodine 123 Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Technetium 99m Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Technetium 99m Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Technetium 99m Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Therapeutic Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Therapeutic Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Therapeutic Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Actinium 225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Actinium 225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Actinium 225 Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Lutetium 177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Lutetium 177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Lutetium 177 Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Radium 223 Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Radium 223 Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Radium 223 Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Yttrium 90 Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Yttrium 90 Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Yttrium 90 Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Medicinal Radiocompounds Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 138. Global Cyclotron Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Cyclotron Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Cyclotron Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Centralized Cyclotron Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Centralized Cyclotron Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Centralized Cyclotron Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Onsite Cyclotron Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Onsite Cyclotron Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Onsite Cyclotron Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Outsourced Cyclotron Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Outsourced Cyclotron Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Outsourced Cyclotron Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Generator Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Generator Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Generator Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global 68Ge/68Ga Generators Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global 68Ge/68Ga Generators Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global 68Ge/68Ga Generators Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global 99Mo/99mTc Generators Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global 99Mo/99mTc Generators Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global 99Mo/99mTc Generators Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Radiopharmacy Synthesis Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Radiopharmacy Synthesis Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Radiopharmacy Synthesis Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Reactor And Accelerator Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Reactor And Accelerator Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Reactor And Accelerator Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Accelerator Sourced Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Accelerator Sourced Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Accelerator Sourced Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Reactor Sourced Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Reactor Sourced Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Reactor Sourced Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Medicinal Radiocompounds Market Size, by Therapeutic Mechanism, 2017-2032 (USD Million)
TABLE 172. Global Antibody Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Antibody Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Antibody Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Antibody Fragments And Conjugates Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Antibody Fragments And Conjugates Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Antibody Fragments And Conjugates Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Cell Based Radiotherapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Cell Based Radiotherapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Cell Based Radiotherapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Nanoparticle Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Nanoparticle Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Nanoparticle Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Peptide Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Peptide Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Peptide Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Peptide Receptor Targeting Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Peptide Receptor Targeting Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Peptide Receptor Targeting Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Radiolabeled Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Radiolabeled Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Radiolabeled Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Small Molecule Targeting Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Small Molecule Targeting Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Small Molecule Targeting Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Medicinal Radiocompounds Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 203. Global Cardiac Viability Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Global Cardiac Viability Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. Global Cardiac Viability Market Size, by Country, 2017-2032 (USD Million)
TABLE 206. Global Myocardial Perfusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Global Myocardial Perfusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. Global Myocardial Perfusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 209. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global Alzheimer Disease Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Global Alzheimer Disease Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. Global Alzheimer Disease Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 215. Global Parkinsonian Disorder Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Global Parkinsonian Disorder Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. Global Parkinsonian Disorder Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. Global General Oncology Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. Global General Oncology Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. Global General Oncology Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 224. Global Neuroendocrine Tumor Imaging And PRRT Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Global Neuroendocrine Tumor Imaging And PRRT Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. Global Neuroendocrine Tumor Imaging And PRRT Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. Global Prostate Cancer Imaging And Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Global Prostate Cancer Imaging And Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. Global Prostate Cancer Imaging And Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. Global Medicinal Radiocompounds Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 234. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 235. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 237. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 238. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 240. Global Nuclear Medicine Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 241. Global Nuclear Medicine Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. Global Nuclear Medicine Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 243. Global Pharmaceutical And Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Global Pharmaceutical And Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. Global Pharmaceutical And Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 246. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 247. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 248. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 249. Global Medicinal Radiocompounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 250. Asia-Pacific Medicinal Radiocompounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 251. Asia-Pacific Medicinal Radiocompounds Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. Asia-Pacific Medicinal Radiocompounds Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 253. Asia-Pacific Medicinal Radiocompounds Market Size, by PET Radiotracers, 2017-2032 (USD Million)
TABLE 254. Asia-Pacific Medicinal Radiocompounds Market Size, by SPECT Radiotracers, 2017-2032 (USD Million)
TABLE 255. Asia-Pacific Medicinal Radiocompounds Market Size, by Theranostic Agents, 2017-2032 (USD Million)
TABLE 256. Asia-Pacific Medicinal Radiocompounds Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 257. Asia-Pacific Medicinal Radiocompounds Market Size, by Alpha Emitters, 2017-2032 (USD Million)
TABLE 258. Asia-Pacific Medicinal Radiocompounds Market Size, by Beta Emitters, 2017-2032 (USD Million)
TABLE 259. Asia-Pacific Medicinal Radiocompounds Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 260. Asia-Pacific Medicinal Radiocompounds Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 261. Asia-Pacific Medicinal Radiocompounds Market Size, by PET Isotopes, 2017-2032 (USD Million)
TABLE 262. Asia-Pacific Medicinal Radiocompounds Market Size, by SPECT Isotopes, 2017-2032 (USD Million)
TABLE 263. Asia-Pacific Medicinal Radiocompounds Market Size, by Therapeutic Isotopes, 2017-2032 (USD Million)
TABLE 264. Asia-Pacific Medicinal Radiocompounds Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 265. Asia-Pacific Medicinal Radiocompounds Market Size, by Cyclotron Produced, 2017-2032 (USD Million)
TABLE 266. Asia-Pacific Medicinal Radiocompounds Market Size, by Generator Produced, 2017-2032 (USD Million)
TABLE 267. Asia-Pacific Medicinal Radiocompounds Market Size, by Reactor And Accelerator, 2017-2032 (USD Million)
TABLE 268. Asia-Pacific Medicinal Radiocompounds Market Size, by Therapeutic Mechanism, 2017-2032 (USD Million)
TABLE 269. Asia-Pacific Medicinal Radiocompounds Market Size, by Antibody Based, 2017-2032 (USD Million)
TABLE 270. Asia-Pacific Medicinal Radiocompounds Market Size, by Peptide Based, 2017-2032 (USD Million)
TABLE 271. Asia-Pacific Medicinal Radiocompounds Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. Asia-Pacific Medicinal Radiocompounds Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 273. Asia-Pacific Medicinal Radiocompounds Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 274. Asia-Pacific Medicinal Radiocompounds Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 275. Asia-Pacific Medicinal Radiocompounds Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. North America Medicinal Radiocompounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 277. North America Medicinal Radiocompounds Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. North America Medicinal Radiocompounds Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 279. North America Medicinal Radiocompounds Market Size, by PET Radiotracers, 2017-2032 (USD Million)
TABLE 280. North America Medicinal Radiocompounds Market Size, by SPECT Radiotracers, 2017-2032 (USD Million)
TABLE 281. North America Medicinal Radiocompounds Market Size, by Theranostic Agents, 2017-2032 (USD Million)
TABLE 282. North America Medicinal Radiocompounds Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 283. North America Medicinal Radiocompounds Market Size, by Alpha Emitters, 2017-2032 (USD Million)
TABLE 284. North America Medicinal Radiocompounds Market Size, by Beta Emitters, 2017-2032 (USD Million)
TABLE 285. North America Medicinal Radiocompounds Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 286. North America Medicinal Radiocompounds Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 287. North America Medicinal Radiocompounds Market Size, by PET Isotopes, 2017-2032 (USD Million)
TABLE 288. North America Medicinal Radiocompounds Market Size, by SPECT Isotopes, 2017-2032 (USD Million)
TABLE 289. North America Medicinal Radiocompounds Market Size, by Therapeutic Isotopes, 2017-2032 (USD Million)
TABLE 290. North America Medicinal Radiocompounds Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 291. North America Medicinal Radiocompounds Market Size, by Cyclotron Produced, 2017-2032 (USD Million)
TABLE 292. North America Medicinal Radiocompounds Market Size, by Generator Produced, 2017-2032 (USD Million)
TABLE 293. North America Medicinal Radiocompounds Market Size, by Reactor And Accelerator, 2017-2032 (USD Million)
TABLE 294. North America Medicinal Radiocompounds Market Size, by Therapeutic Mechanism, 2017-2032 (USD Million)
TABLE 295. North America Medicinal Radiocompounds Market Size, by Antibody Based, 2017-2032 (USD Million)
TABLE 296. North America Medicinal Radiocompounds Market Size, by Peptide Based, 2017-2032 (USD Million)
TABLE 297. North America Medicinal Radiocompounds Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. North America Medicinal Radiocompounds Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 299. North America Medicinal Radiocompounds Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 300. North America Medicinal Radiocompounds Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 301. North America Medicinal Radiocompounds Market Size, by End User, 2017-2032 (USD Million)
TABLE 302. Latin America Medicinal Radiocompounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 303. Latin America Medicinal Radiocompounds Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. Latin America Medicinal Radiocompounds Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 305. Latin America Medicinal Radiocompounds Market Size, by PET Radiotracers, 2017-2032 (USD Million)
TABLE 306. Latin America Medicinal Radiocompounds Market Size, by SPECT Radiotracers, 2017-2032 (USD Million)
TABLE 307. Latin America Medicinal Radiocompounds Market Size, by Theranostic Agents, 2017-2032 (USD Million)
TABLE 308. Latin America Medicinal Radiocompounds Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 309. Latin America Medicinal Radiocompounds Market Size, by Alpha Emitters, 2017-2032 (USD Million)
TABLE 310. Latin America Medicinal Radiocompounds Market Size, by Beta Emitters, 2017-2032 (USD Million)
TABLE 311. Latin America Medicinal Radiocompounds Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 312. Latin America Medicinal Radiocompounds Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 313. Latin America Medicinal Radiocompounds Market Size, by PET Isotopes, 2017-2032 (USD Million)
TABLE 314. Latin America Medicinal Radiocompounds Market Size, by SPECT Isotopes, 2017-2032 (USD Million)
TABLE 315. Latin America Medicinal Radiocompounds Market Size, by Therapeutic Isotopes, 2017-2032 (USD Million)
TABLE 316. Latin America Medicinal Radiocompounds Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 317. Latin America Medicinal Radiocompounds Market Size, by Cyclotron Produced, 2017-2032 (USD Million)
TABLE 318. Latin America Medicinal Radiocompounds Market Size, by Generator Produced, 2017-2032 (USD Million)
TABLE 319. Latin America Medicinal Radiocompounds Market Size, by Reactor And Accelerator, 2017-2032 (USD Million)
TABLE 320. Latin America Medicinal Radiocompounds Market Size, by Therapeutic Mechanism, 2017-2032 (USD Million)
TABLE 321. Latin America Medicinal Radiocompounds Market Size, by Antibody Based, 2017-2032 (USD Million)
TABLE 322. Latin America Medicinal Radiocompounds Market Size, by Peptide Based, 2017-2032 (USD Million)
TABLE 323. Latin America Medicinal Radiocompounds Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. Latin America Medicinal Radiocompounds Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 325. Latin America Medicinal Radiocompounds Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 326. Latin America Medicinal Radiocompounds Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 327. Latin America Medicinal Radiocompounds Market Size, by End User, 2017-2032 (USD Million)
TABLE 328. Europe Medicinal Radiocompounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 329. Europe Medicinal Radiocompounds Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 330. Europe Medicinal Radiocompounds Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 331. Europe Medicinal Radiocompounds Market Size, by PET Radiotracers, 2017-2032 (USD Million)
TABLE 332. Europe Medicinal Radiocompounds Market Size, by SPECT Radiotracers, 2017-2032 (USD Million)
TABLE 333. Europe Medicinal Radiocompounds Market Size, by Theranostic Agents, 2017-2032 (USD Million)
TABLE 334. Europe Medicinal Radiocompounds Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 335. Europe Medicinal Radiocompounds Market Size, by Alpha Emitters, 2017-2032 (USD Million)
TABLE 336. Europe Medicinal Radiocompounds Market Size, by Beta Emitters, 2017-2032 (USD Million)
TABLE 337. Europe Medicinal Radiocompounds Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 338. Europe Medicinal Radiocompounds Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 339. Europe Medicinal Radiocompounds Market Size, by PET Isotopes, 2017-2032 (USD Million)
TABLE 340. Europe Medicinal Radiocompounds Market Size, by SPECT Isotopes, 2017-2032 (USD Million)
TABLE 341. Europe Medicinal Radiocompounds Market Size, by Therapeutic Isotopes, 2017-2032 (USD Million)
TABLE 342. Europe Medicinal Radiocompounds Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 343. Europe Medicinal Radiocompounds Market Size, by Cyclotron Produced, 2017-2032 (USD Million)
TABLE 344. Europe Medicinal Radiocompounds Market Size, by Generator Produced, 2017-2032 (USD Million)
TABLE 345. Europe Medicinal Radiocompounds Market Size, by Reactor And Accelerator, 2017-2032 (USD Million)
TABLE 346. Europe Medicinal Radiocompounds Market Size, by Therapeutic Mechanism, 2017-2032 (USD Million)
TABLE 347. Europe Medicinal Radiocompounds Market Size, by Antibody Based, 2017-2032 (USD Million)
TABLE 348. Europe Medicinal Radiocompounds Market Size, by Peptide Based, 2017-2032 (USD Million)
TABLE 349. Europe Medicinal Radiocompounds Market Size, by Application, 2017-2032 (USD Million)
TABLE 350. Europe Medicinal Radiocompounds Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 351. Europe Medicinal Radiocompounds Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 352. Europe Medicinal Radiocompounds Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 353. Europe Medicinal Radiocompounds Market Size, by End User, 2017-2032 (USD Million)
TABLE 354. Middle East Medicinal Radiocompounds Market Size, by Region, 2017-2032 (USD Million)
TABLE 355. Middle East Medicinal Radiocompounds Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 356. Middle East Medicinal Radiocompounds Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 357. Middle East Medicinal Radiocompounds Market Size, by PET Radiotracers, 2017-2032 (USD Million)
TABLE 358. Middle East Medicinal Radiocompounds Market Size, by SPECT Radiotracers, 2017-2032 (USD Million)
TABLE 359. Middle East Medicinal Radiocompounds Market Size, by Theranostic Agents, 2017-2032 (USD Million)
TABLE 360. Middle East Medicinal Radiocompounds Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million

Companies Mentioned

  • Advanced Accelerator Applications S.A.
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Cardinal Health Inc.
  • Curium Pharma US LLC
  • GE Healthcare
  • Ion Beam Applications S.A.
  • Jubilant Radiopharma Pvt Ltd.
  • Lantheus Medical Imaging Inc.
  • Mallinckrodt Pharmaceuticals
  • Nordion Inc.
  • Novartis AG
  • PETNET Solutions Inc.
  • RadioMedix Inc.
  • Siemens Healthineers AG
  • Telix Pharmaceuticals Limited

Related Reports

PET Radiotracer Market - Global Forecast 2026-2032 - Product Image

PET Radiotracer Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Nuclear Medicine Radioisotopes Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine Radioisotopes Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Medical Cyclotron Market - Global Forecast 2026-2032 - Product Image

Medical Cyclotron Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Nuclear Medicine Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Medicinal Exosomes Market - Global Forecast 2026-2032 - Product Image

Medicinal Exosomes Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.